TB Research

Clinical case of an unusual course of coronavirus infection in patient with chronic disseminated pulmonary tuberculosis and human immunodeficiency virus infection

V. L. Dobin, Alexei V. Gorbunov, Yevgeniy N. Muratov

I P Pavlov Russian Medical Biological Herald · 2021-12

Abstract

Introduction: The coronavirus 2019 (COVID-19) pandemic demonstrated a negative influence on many underlying diseases, their course, and prognosis. A combined course of active tuberculosis, human immunodeficiency virus (HIV) infection, and COVID-19 is a rare case in the routine clinical practice; therefore, it is of scientific and practical interest. In a 41-year-old patient with severe chronic disseminated pulmonary tuberculosis and HIV infection, presence of tuberculosis mycobacteria, resistance to streptomycin and isoniazid, chronic respiratory failure, cachexia, and immunodeficiency, COVID-19 was manifested only by the detection of SARS-Cov-2 virus from the nasopharynx and did not influence the treatment and prognosis of tuberculosis. Conclusion: The described case of a combination of active tuberculosis with HIV infection and COVID-19 demonstrated that effective treatment of specific tuberculosis process is quite possible.

MeSH terms

  • Tuberculosis
  • Medicine
  • Immunology
  • Coronavirus
  • Cachexia
  • Virology
  • Human immunodeficiency virus (HIV)
  • Immunodeficiency
  • Isoniazid
  • Virus
  • Pandemic